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Abstract
Background: Previous researches reveal that depression is associated with increased inflammatory markers. As a
simple and cheap inflammatory marker, we hypothesize that neutrophilic granulocyte percentage is associated with
depression in hospitalized heart failure patients, whose prevalence of depression is at a very high level.
Methods: Three hundred sixty-six cases of hospitalized heart failure patients with left ventricular ejection fraction
(LVEF) ≤45% and New York Heart Association (NYHA) class II-IV were enrolled. All the enrolled patients received
Hamilton Rating Scale for Depression (24-items) (HAM-D24). The demographic, clinical data, blood samples and
echocardiography were documented. The Pearson simple linear correlation was performed to evaluate the
confounding factors correlated with HAM-D24 depression index. The significantly correlated factors were enrolled as
independent variables in Logistic regression to determine the risk or protective factors for depression, which was
taken as dependent variable.
Results: Two hundred ten cases of hospitalized heart failure patients (57.4%) had depression. Among them, 134
patients (63.8%) had mild depression, 58 patients (27.6%) had moderate depression and 18 patients (8.6%) had
severe depression. Pearson simple linear correlation revealed that in hospitalized patients with heart failure, the
neutrophils granulocyte percentage was positively correlated with the HAM-D24 depression index (r = .435,
p < .001). After the adjustment of age, BMI, number of members of the household, smoking index, New York
Heart Association (NYHA) classification, hemoglobin, TC, LDL-C, creatinine, cystatin-C, TBIL and albumin, the
neutrophils granulocyte percentage is still significantly associated with depression in hospitalized heart failure
patients (OR = 1.046, p < .001).
Conclusions: The neutrophils granulocyte percentage may be used as a new marker for depression in hospitalized
heart failure patients.
Keywords: Neutrophilic granulocyte percentage, Depression, Hospitalized heart failure
Background
Heart failure is the end stage of all cardiovascular diseases,
it mainly shows symptoms of dyspnea and edema, which
severely affect exercise capacity and quality of life. Heart
failure is prevalent around the globe, an estimated 5.7
million Americans have heart failure [1], and there are at
least 15 million patients with heart failure in Europe [2].
Eleven million patients suffered from heart failure in the
year 2010 in China [3]. Heart failure is one major cause of
death and disability. Even though extensive pharmacologic
and device therapeutics were developed for heart failure,
the morbidity and mortality is still high in heart failure
patients [4].
Depression is common in heart failure, with a reported
prevalence of 21.5% in a meta-analysis [5]. However, the
depression may be still under-diagnosed with the highest
prevalence of up to 77.5% in one cohort study [6].
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Depression is one of many factors associated with poor
prognosis in heart failure patients [7–9]. It has been
reported to be independently associated with poor qual-
ity of life, limited functional status, and increased risk of
morbidity and mortality in this population [10–14].
Previous researches reveal that depression is associated
with increased inflammatory markers including C-
reactive protein (CRP), interleukin-1, and interleukin-6
[15–17]. One study reports that the increased neutro-
phil/lymphocyte ratio is correlated with the severity of
depression in patients with depression [18]. As one of
the important indicator of inflammation, neutrophilic
granulocyte percentage is cheap and simple test con-
tained in blood routine test. We hypothesized that such
an easily attained test result may be have certain associ-
ation with depression and be used in predicting the
depression in highly depressed heart failure patients. So
far, the association between the neutrophilic granulocyte
percentage and depression were not reported in such a
population. Therefore, the aim of the present study is to
investigate the association between the neutrophilic




We performed this present cross-sectional and observa-
tional study in 1st Cardiology Department of People’s
Hospital of Shaanxi Province from January 2015 to June
in 2016. We enrolled hospitalized patients with left
ventricular ejection fraction (LVEF) ≤45% and New York
Heart Association (NYHA) class II-IV heart failure
symptoms. New York Heart Association (NYHA) class
II is defined as mild symptoms (mild shortness of breath
and/or angina) and slight limitation during ordinary ac-
tivity. New York Heart Association (NYHA) class III is
defined as marked limitation in activity due to symp-
toms, even during less-than-ordinary activity, comfort-
able only at rest. New York Heart Association (NYHA)
class IV is defined as severe limitations in activity, even
while at rest, who are mostly bedbound patients [19].
Heart failure was confirmed by clinical heart failure
specialist and cardiologists after consulting with the
echocardiography report. The main exclusion criteria
included significant cognitive impairment, alcohol or
drug dependence within the previous year, psychoses,
bipolar disorder, severe personality disorder, active sui-
cidal ideation, life-threatening comorbidity, and current
use of antipsychotic or antidepressant medications [20].
Three hundred eighty-five hospitalized patients with
heart failure were screened, a total 19 patients were
excluded. 8 persons were excluded as they were taking
alprazolam and diazepam, 3 persons were excluded since
they were heavy alcohol users, 4 persons were excluded
as they had severe cognitive impairment after stroke, 2
persons were excluded as they suffered continuous
dyspea and edema till death, 2 persons were excluded as
they are not willing to cooperate. Among the enrolled
366 hospitalized patients, 200 (54.6%) patients were male
and 166 (45.4%) patients were female. The average age
was 62.56 ± 10.74 years.
Depression assessments
The heart failure patients were evaluated for depressive
symptoms by using Hamilton Rating Scale for Depres-
sion (24-items) (HAM-D24), it contained a total of 24
items (10 item was defined from 0 to 2, and 14 items
were defined from 0 to 4). Questions of 0–2 points were
defined as none (0), mild-moderate (1), severe (2). Ques-
tions of 0–4 points were defined as none (0), mild (1),
moderate (2), severe (3), very severe (4). HAM-D24 score
<8 points was defined as non-depression and HAM-D24
score ≥8 points was defined as depression. HAM-D24
score of 8–19 points was defined as mild depression,
HAM-D24 score of 20–34 points was defined as moder-
ate depression, HAM-D24 score of ≥35 points was
defined as severe depression [21]. The measurements of
HAM-D24 were conducted by trained physicians on the
first day after admission. Two physicians in our depart-
ment were sent to psychology department for a week to
learn the talking, observing and interpreting skill of
HAM-D24. The two physicians independently scores for
each patients, the mean scores taken by the physicians
were used as the final score. If the two scores were
severely diverted, the repeated test will be performed by
a psychologist in psychology department.
Demographic and clinical data
Demographic data and cardiovascular risk factors were
obtained from the medical records. Body weight was
measured while the subjects were without shoes by
using a double balance placed on a firm surface. Height
was measured by using a Frankfort plane positioned at a
90° angle against a wall-mounted metal tape. The waist
circumference measurements were taken at the end of
normal expiration and to the nearest 0.1 cm, measuring
from the narrowest point between the lower borders of
the rib cage and the iliac crest [22].
Blood samples and echocardiography
Peripheral blood was sampled from patients in a fasting
state on the morning following the admission day.
Venous blood samples were sent to Clinical Laboratory
Department of People’s Hospital of Shaanxi Province for
red blood cells (RBC) counts, hemoglobin, platelet
counts, plateletcrit, mean platelet volume (MPV), plate-
let distribution width (PDW), white blood cells (WBC)
counts, neutrophilic granulocyte percentage (NEUT%),
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total cholesterol (TC), triglyceride, high-density lipoprotein-
cholesterol (HDL-C), low-density lipoprotein-cholesterol
(LDL-C), apolipoprotein A, apolipoprotein B, urea nitrogen
(BUN), creatinine, cystatin-C, total bilirubin (TBIL), direct
bilirubin (DBIL), total protein (TP), albumin, brain natri-
uretic peptide (BNP) and fasting glucose (FG) detection
using standard biochemical techniques. Echocardiographic
data (left ventricular ejection fraction [LVEF]) was obtained
using Doppler echocardiography conducted within 3 days
of admission [23].
Definition of risk factors
Hypertension was defined as an average systolic blood
pressure ≥ 140 mmHg, or an average diastolic blood
pressure ≥ 90 mmHg, or both, or self-reported use of
antihypertensive medication, or a self-reported history of
hypertension.
Diabetes was defined as fasting plasma glucose ≥
7.0 mmol/L, or random plasma glucose ≥ 11.1 mmol/L,
or 2 h plasma glucose in oral glucose tolerance test
(OGTT) ≥ 11.1 mmol/L, or use of insulin or oral
hypoglycemic agents, or a self-reported history of
diabetes.
Coronary artery disease was defined as the presence of
at least one significant coronary artery stenosis of more
than 50% luminal diameter in coronary angiography or
coronary computed tomographic angiography (CTA).
Atrial fibrillation was diagnosed mainly via electrocar-
diogram (ECG), characteristic findings included absence
of P waves and irregular R-R intervals.
Dilated cardiomyopathy was diagnosed mainly via
echocardiogram, which showed left ventricular dilatation
with normal or thinned walls and reduced ejection frac-
tion. Meanwhile, the history of coronary artery disease,
hypertension, valvular heart disease and other heart
diseases should be excluded before making the present
diagnosis.
Smoking index was defined as number of cigarettes
smoked per day × years of smoking.
BMI was calculated as weight in kg divided by height
in m2.
Statistical analysis
The statistical analysis was conducted using SPSS
version 16.0 for Windows (SPSS Inc., Chicago, IL, USA).
Continuous variables were expressed as mean ± standard
deviations and the differences between the depression
group and non-depression group were analyzed using
the Mann-Whitney U-test. Categorical variables were
expressed as proportions and the differences in cate-
gorical variables were analyzed using chi-square test.
Pearson correlation analysis was conducted to determine
the correlation between HAM-D24 score and each clin-
ical and laboratory factor. Logistic regression model was
established to determine whether neutrophilic granulo-
cyte percentage was significantly associated with depres-
sion after the adjustment of each confounding factor.
Statistical significance was established at p < 0.05.
Results
The baseline characteristics of hospitalized heart failure
patients with and without depression were shown in
Table 1. Two hundred ten patients developed depression
accounting for 57.4% of all hospitalized patients with
heart failure. Among them, 134 patients (63.8%) had
mild depression, 58 patients (27.6%) had moderate
depression and 18 patients (8.6%) had severe depression.
31.3% of male patients had depression while 68.7% of
female patients had depression, the distribution of
depression between men and women was statistically
significant. The distribution of depression in each New
York Heart Association (NYHA) classification also var-
ied significantly, the depression rates increased dramatic-
ally in patients with New York Heart Association
(NYHA) class III and class IV. The incidence of coron-
ary artery disease and diabetes mellitus showed signifi-
cant differences between the two groups. The incidence
of diabetes was higher in heart failure patients with
depression while the incidence of coronary artery disease
was lower in heart failure patients with depression when
compared with that in heart failure patients without
depression. The smoking index, platelet counts, platelet-
crit, NEUT%, TC, triglyceride, LDL-C, apolipoprotein B,
BUN, creatinine, cystatin-C, BNP and HAM-D24 score
were significantly higher in heart failure patients with
depression when compare with those without depres-
sion. Meanwhile, the waist circumference, monthly
family income and hemoglobin and left ventricular
ejection fraction (LVEF) were significantly lower in heart
failure patients with depression when compare with
those without depression. The habitant area, the incidence
of hypertension, atrial fibrillation and dilated cardiomyop-
athy, age, BMI, number of members of the household,
RBC counts, MPV, PDW, WBC counts, HDL-C, apolipo-
protein A, TBIL, DBIL, TP, albumin and FG showed no
significant difference between the heart failure patients
with depression and ones without depression.
Pearson correlation analysis between HAM-D24 score
and clinical and laboratory factors in hospitalized heart
failure patients were shown in Table 2. The age, number
of members of the household, smoking index, New York
Heart Association (NYHA) classification, NEUT%, TC,
LDL-C, BUN, creatinine, cystatin-C, TBIL, DBIL and
BNP showed significantly positive correlation with HAM-
D24 score in hospitalized heart failure patients. The correl-
ation coefficient between NEUT% and HAM-D24 score
was 0.435 (p < .001), which was the second highest correl-
ation coefficient with HAM-D24 in all the confounding
Pan et al. BMC Psychiatry  (2016) 16:446 Page 3 of 9
Table 1 Baseline characteristics of hospitalized heart failure patients with and without depression
Without depression (n = 156) With Depression (n = 210) p value
Sex <.001
Men 104 (52.0%) 96 (31.3%)
Women 52 (48.0%) 114 (68.7%)
Habitant area .069
Urban area 108 (46.2%) 48 (36.4%)
Rural area 126 (53.8%) 84 (63.6%)
NYHA classification <.001
II 144 (92.3%) 122 (58.1%)
III 8 (5.1%) 68 (32.4%)
IV 4 (2.6%) 20 (9.5%)
Coronary artery disease 138 (88.5%) 164 (78.1%) .010
Hypertension 90 (57.7%) 116 (55.2%) .640
Atrial fibrillation 26 (16.7%) 48 (22.9%) .145
Dilated cardiomyopathy 8 (5.1%) 18 (8.6%) .205
Diabetes mellitus 42 (26.9%) 78 (37.1%) .039
Age (years) 62.55 ± 9.56 62.58 ± 11.61 .723
BMI (kg/m2) 23.82 ± 2.73 23.46 ± 4.33 .404
Waist circumference (cm) 86.18 ± 8.71 84.16 ± 10.29 .017
Monthly family income (yuan) 3869.23 ± 3118.49 3019.05 ± 1782.27 .003
Number of members of the household (person) 4.04 ± 1.27 3.88 ± 1.35 .199
Smoking index 73.97 ± 203.39 100.14 ± 190.25 <.001
RBC counts (×1012/L) 4.35 ± 0.49 4.21 ± 0.60 .091
Hemoglobin (g/L) 135.24 ± 16.05 131.00 ± 18.37 .035
Platelet counts (×109/L) 176.54 ± 45.62 190.26 ± 58.96 .018
Plateletcrit (%) 0.18 ± 0.05 0.19 ± 0.05 .021
MPV (fL) 10.33 ± 1.48 10.30 ± 1.31 .954
PDW (fL) 16.45 ± 2.28 16.24 ± 2.05 .127
WBC counts (×109/L) 6.93 ± 5.00 6.54 ± 1.82 .285
NEUT% (%) 30.69 ± 32.60 63.31 ± 12.13 <.001
TC (mmol/L) 3.95 ± 0.88 4.67 ± 1.13 <.001
Triglyceride (mmol/L) 1.40 ± 0.69 1.76 ± 1.18 .015
HDL-C (mmol/L) 1.19 ± 0.28 1.18 ± 0.36 .390
LDL-C (mmol/L) 1.87 ± 0.60 2.26 ± 0.77 <.001
Apolipoprotein A (g/L) 1.14 ± 0.21 1.14 ± 0.27 .748
Apolipoprotein B (g/L) 0.72 ± 0.19 1.22 ± 3.47 <.001
BUN (mmol/L) 5.82 ± 2.51 6.65 ± 3.50 .046
Creatinine (umol/L) 73.98 ± 24.26 85.63 ± 40.81 .001
Cystatin-C (mg/L) 1.09 ± 0.32 1.27 ± 0.54 .001
TBIL (umol/L) 17.12 ± 8.90 18.63 ± 15.39 .913
DBIL (umol/L) 5.94 ± 3.13 6.67 ± 6.94 .410
TP (g/L) 64.04 ± 5.70 63.08 ± 6.15 .134
Albumin (g/L) 38.34 ± 5.47 37.51 ± 4.91 .343
BNP (pg/mL) 364.15 ± 832.65 601.65 ± 986.63 <.001
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factors. Meanwhile, the BMI, RBC counts, hemoglobin, al-
bumin and left ventricular ejection fraction (LVEF)
showed significantly negative correlation with HAM-D24
score in hospitalized heart failure patients. The waist cir-
cumference, monthly family income, platelet counts, pla-
teletcrit, MPV, PDW, WBC counts, triglyceride, HDL-C,
apolipoprotein A, apolipoprotein B, TP, FG showed no sig-
nificant correlation with HAM-D24 score in hospitalized
heart failure patients.
Logistic regression analysis for HAM-D24 determined
depression using neutrophilic granulocyte percentage
and each confounding factor in hospitalized heart failure
patients were presented in Table 3. We enrolled all the
factors significantly correlated with HAM-D24 score ex-
cept for RBC counts, BUN, DBIL, BNP and left ventricu-
lar ejection fraction (LVEF) in the Logistic regression.
Since the highly tight correlations were found between
hemoglobin and RBC counts, BUN and creatinine, DBIL
and TBIL, New York Heart Association (NYHA) classifi-
cation and BNP, left ventricular ejection fraction (LVEF)
in clinical practices, we considered it inappropriate if we
put all the highly correlated factors in one Logistic re-
gression model. Therefore, we chose the hemoglobin,
creatinine, TBIL and New York Heart Association
(NYHA) classification in the Logistic regression model
rather than RBC counts, BUN, DBIL, BNP and left ven-
tricular ejection fraction (LVEF). After the adjustment of
age, BMI, number of members of the household, smok-
ing index, New York Heart Association (NYHA) classifi-
cation, hemoglobin, TC, LDL-C, creatinine, cystatin-C,
TBIL and albumin, NEUT% is still significantly associ-
ated with depression in hospitalized heart failure pa-
tients (OR = 1.046, p < .001).
Discussions
The present study revealed that correlation coef-
ficient between NEUT% and HAM-D24 score was
0.435 (p < .001). Then the Logistic regression model
confirmed that NEUT% is still associated with depression
in hospitalized heart failure patients with the adjustment
of age, BMI, number of members of the household, smok-
ing index, New York Heart Association (NYHA) classifi-
cation, hemoglobin, TC, LDL-C, creatinine, cystatin-C,
TBIL and albumin (OR = 1.046, p < .001). The mechanism
that the NEUT% was associated with depression in heart
failure patients is still unclear. The possible reason may be
Table 1 Baseline characteristics of hospitalized heart failure patients with and without depression (Continued)
FG (mmol/L) 6.63 ± 1.54 7.66 ± 2.78 .148
LVEF (%) 39.29 ± 3.25 35.59 ± 6.94 <.001
HAM-D24 score 4.32 ± 1.67 17.58 ± 8.36 <.001
NYHA New York Heart Association, BMI body mass index, RBC red blood cells, MPV mean platelet volume, PDW platelet distribution width, WBC white blood cells,
NEUT% neutrophilic granulocyte percentage, TC total cholesterol, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, BUN urea
nitrogen, TBIL total bilirubin, DBIL direct bilirubin, TP total protein, BNP brain natriuretic peptide, FG fasting glucose, LVEF left ventricular ejection fraction
Table 2 Pearson correlation analysis between HAM-D24 score





Waist circumference -.076 .149
Monthly family income -.076 .147
Number of members of the household .143 .006*
Smoking index .103 .048*
NYHA classification .603 <.001*
RBC counts -.189 <.001*
Hemoglobin -.146 .007*










Apolipoprotein A -.089 .099











HAM-D24Hamilton rating scale for depression (24 items), BMI body mass index,
NYHA New York Heart Association, RBC red blood Cells, MPV mean platelet volume,
PDW platelet distribution width, WBC white blood cells, NEUT% neutrophilic
granulocyte percentage, TC total cholesterol, HDL-C high-density lipoprotein-
cholesterol, LDL-C low-density lipoprotein-cholesterol, BUN urea nitrogen, TBIL
total bilirubin, DBIL direct bilirubin, TP total protein, BNP brain natriuretic peptide,
FG fasting glucose, LVEF left ventricular ejection fraction; *P < 0.05
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as follows. As an important indicator for inflammation,
the neutrophilic granulocytes would be activated firstly
when responding to inflammation exposure. The activated
neutrophilic granulocytes, which can be interpreted as
increased NEUT% may be accompanied with elevated
inflammatory cytokines secretion causing heavier oxida-
tive stress and further inflammation. Meanwhile, some
studies [24, 25] found that in patients with severe depres-
sive disorder, the activation of proinflammatory cytokines
and inhibition of interferon-gamma, interleukin-2, and
interleukin-4 were documented. Therefore, we believe that
the activation of inflammation may play the key role in
the association with depression. The heart failure may
amplify the association via the increase of inflammation
and oxidative stress. However, the causal relationship
between the inflammation and depression needs to be
further clarified.
The present study showed that the depression rates
increased dramatically in patients with New York Heart
Association (NYHA) class III and class IV, we also found
that the predictors of severity of heart failure, such as
New York Heart Association (NYHA) classification,
BNP, and EF were all significantly correlated with HAM-
D24 score (all p < .001). The correlation coefficients were
0.603 for New York Heart Association (NYHA) classifi-
cation, −0.271 for left ventricular ejection fraction
(LVEF) and 0.243 for BNP, the New York Heart Associ-
ation (NYHA) classification was proved to be a risk
factor after adjustment of other confounding factors
(OR = 2.757, p = .005). Relevant research has also shown
a higher prevalence of depression in patients with more
severe heart failure [26, 27]. Pena et al. [28] showed that
heart failure patients in New York Heart Association
(NYHA) grade IV were more depressed than those in
New York Heart Association (NYHA) grades II or III.
Gottlieb et al. [6] demonstrated that patients classified as
New York Heart Association (NYHA) class III and IV
were more likely to be depressed than class II patients. In
their meta-analysis, Rutledge et al. [5] demonstrated that
higher prevalencerates were associated with worse New
York Heart Association (NYHA) class. Polikandrioti et al.
[4] found that higher levels of depression were observed
for heart failure patients in New York Heart Association
(NYHA) II and NYHA III compared to those in grade I.
In this present study, we found that the traditional risk
factors for heart failure were significantly correlated with
HAM-D24 score. A part of the reason may be that
anemia (counts and hemoglobin), dyslipidemia (TC and
LDL-C), kidney dysfunction (BUN, creatinine and
cystatin-C) and liver dysfunction (TBIL, DBIL and albu-
min) were classical features accompanied with heart
function deterioration, as the heart function decreased,
the symptoms of heart failure began to appear, which
may cause the depression in this population [29–32].
Besides these traditional factors, the present study re-
vealed 4 demographic factors significantly correlated
with HAM-D24 score. First, HAM-D24 score increased
as patients got elder, considering that the cardiovascular
diseases were highly age related, it is not difficult to
understand that depression level will rise with increase
of age. Second, BMI would decrease as the increase of
depression level, a majority of heart failure patients had
sodium and water retention, remission of sodium and
water retention will lead to some weight loss, which will
improve symptoms of heart failure and depression [33].
Third, larger number of members of the household was
Table 3 Logistic regression analysis for HAM-D24 determined depression using neutrophilic granulocyte percentage and each
confounding factor in hospitalized heart failure patients
Odd ratios 95% CI p value
Age 0.988 0.959–1.018 .420
BMI 0.996 0.914–1.086 .933
Number of members of the household 0.945 0.754–1.184 .622
Smoking index 1.000 0.998–1.002 .830
NYHA classification 2.757 1.361–5.586 .005*
Hemoglobin 0.987 0.967–1.007 .191
NEUT% 1.046 1.029–1.063 <.001*
TC 2.038 1.213–3.424 .007*
LDL-C 0.942 0.459–1.933 .871
Creatinine 0.996 0.976–1.016 .703
Cystatin-C 1.589 0.420–6.017 .495
TBIL 0.994 0.966–1.023 .693
Albumin 0.952 0.897–1.011 .111
HAM-D24 Hamilton rating scale for depression (24 items), CI confidence interval, BMI body mass index, NYHA New York Heart Association, NEUT% neutrophilic
granulocyte percentage, TC total cholesterol, LDL-C low-density lipoprotein-cholesterol, TBIL total bilirubin; *P < 0.05
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correlated with more depression. This was an interesting
Chinese phenomenon that the more number of mem-
bers of the household did not mean more family support
and less loneliness, it meant more argument and rela-
tively less space in the room for each person. Fourth,
smoking index significantly increased as HAM-D24 score
increased. It was also an interesting phenomenon that
smoking may not necessarily bring you happiness and
relief, it made you more depressed if you had heart fail-
ure. The reason may be that smoking activated the
process of arteriosclerosis making you more vulnerable
to the harm of cardiovascular disease [34].
By using HAM-D24 score, a convenient and accurate
tool for the depression evaluation [35, 36], the present
study showed that 57.4% of all hospitalized patients with
heart failure had depression. The prevalence of depres-
sion in heart failure patients varied dramatically in pre-
vious studies. Rutledge et al. [5] reported the prevalence
of depression as 21.5% in a meta-analytic review.
Rafanelli et al. [37] who studied both hospitalized pa-
tients and outpatients with heart failure, showed that
38.1% of the sample experienced depression. One study
in Greek population [38] showed that 41.6% of hospital-
ized patients with heart failure appeared to have depres-
sion. Gottlieb et al. [6] reported depression rates among
hospitalized patients of 13 to 77.5% and rates for outpa-
tients from 13 to 42%. Vaccarino et al. [39] showed that
78% of hospitalized heart failure patients experienced
depressive symptoms. These differences in the preva-
lence of depression in heart failure patients are possibly
attributable to differences in enrollment criteria, diag-
nostic instruments, the definition and classification of
depression, and the severity of heart failure. This high-
lights the importance of using a universally accepted
measuring instrument that will allow comparisons be-
tween populations.
Our study has several strengths. First, we provide
clinical and laboratory data in hospitalized heart failure
patients divided by depression and the relationship
between the confounding factors and depression, which
conveyed valuable clue for other studies searching new
risk factors for depression in hospitalized heart failure
patients. Second, we have shown for the first time the
association between NEUT% and depression in hospital-
ized heart failure patients. Third, the blood routine test
is a simple, cheap and commonly used test, so NEUT%
can be easily acquired. NEUT% would present us with
new insight into the depression status in hospitalized
heart failure patients.
Our study has several limitations. This study was a
cross-sectional and observational study, the causal rela-
tionship between NEUT% and depression need to be
further clarified. Further cohort studies may provide
treatment to patients with depression and then evaluate
whether the NEUT% showed the decrease trend after
the depression was alleviated in this population. Since
the patients with severe and very severe level depression
were limited, we did not further divide our patients into
different groups according to severity of depression.
Therefore, further larger scale, prospective studies are
needed to explore extensive information in patients di-
vided according to severity of depression. Third, we used
the self-reported history of hypertension and diabetes in
the paper, which may underestimate the actual incidence
of hypertension and diabetes in the enrolled patients.
Fourth, according to Bonferroni correction, the significant
of TC as a risk factor for depression should be further
considered since the p value should be divided by 13 (13
independent factors) in logistic regression analysis.
Conclusions
In conclusion, NEUT% was significantly and positively
correlated with HAM-D24 score in hospitalized heart fail-
ure patients. Moreover, after the adjustment of confound-
ing factors, the NEUT% is independently associated with
depression, it can be used as an new marker for depres-
sion in hospitalized heart failure patients. In the future, a
simple and cheap NEUT% test may provide insight into
depression status and should be included in psychiatric
evaluation in hospitalized heart failure patients.
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